找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cell Death Signaling in Cancer Biology and Treatment; Daniel E. Johnson Book 2013 Springer Science+Business Media New York 2013 Cancer.Can

[复制链接]
楼主: Fillmore
发表于 2025-3-23 10:20:08 | 显示全部楼层
Harnessing Death Receptor Signaling for Cancer Treatment,ne side and cell proliferation on the other side toward survival promotes tumor formation. The death receptor (extrinsic) pathway represents one of the major apoptosis signaling cascades, which links exogenous stimuli via transmembrane surface receptors to the intracellular signaling machinery that
发表于 2025-3-23 17:01:47 | 显示全部楼层
发表于 2025-3-23 19:55:57 | 显示全部楼层
New Agents and Approaches for Targeting the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR Cell Survival Pathwayutations in intrinsic pathway components. Upstream mutations in one signaling pathway or even in downstream components of the same pathway can alter the sensitivity of the cells to certain small molecule inhibitors. These pathways have profound effects on proliferative, apoptotic, and differentiatio
发表于 2025-3-24 00:04:59 | 显示全部楼层
发表于 2025-3-24 03:09:43 | 显示全部楼层
2625-2902 clinical approaches.Features development and application of A key goal in the treatment of cancer is to achieve selective and efficient killing of tumor cells. The aim of .Cell Death Signaling in Cancer Biology and Treatment. is to describe state-of-the-art approaches and future opportunities for ac
发表于 2025-3-24 09:56:41 | 显示全部楼层
发表于 2025-3-24 12:48:41 | 显示全部楼层
发表于 2025-3-24 18:37:09 | 显示全部楼层
发表于 2025-3-24 20:32:03 | 显示全部楼层
发表于 2025-3-24 23:34:07 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-26 19:55
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表